Here we studied minimal residual disease ( MRD ) of patients with acute myeloid leukemia ( AML ) who have PML/RAR alpha or AML1/ETO as well as the phenotypic analysis of lymphocyte subsets involved in antitumor immunity .
here we studied minimal residual disease ( mrd ) of patients with acute myeloid leukemia ( aml ) who have pml/rar alpha or aml1/eto as well as the phenotypic analysis of lymphocyte subsets involved in antitumor immunity .
O O O B-other_name I-other_name I-other_name O B-other_name O O B-multi_cell O B-other_name I-other_name I-other_name O B-other_name O O O B-protein_molecule I-protein_molecule O B-protein_molecule O O O O B-other_name I-other_name O B-cell_type I-cell_type O O B-other_name I-other_name O